Net Loss (USD, thousands)

Depreciation (USD, thousands)

Amortization of Acquisition Related Intangible Assets (USD, thousands)

Non-Cash Operating Lease Cost (USD, thousands)

Stock-Based Compensation Expense (USD, thousands)

Provision for Credit Losses (USD, thousands)

Provision for Inventory (USD, thousands)

Accounts Receivable, Changes in Operating Assets and Liabilities (USD, thousands)

Inventories, Changes in Operating Assets and Liabilities (USD, thousands)

Prepaid Expenses, Other Current and Long-Term Assets, Changes in Operating Assets and Liabilities (USD, thousands)

Accounts Payable, Changes in Operating Assets and Liabilities (USD, thousands)

Operating Lease Liabilities, Changes in Operating Assets and Liabilities (USD, thousands)

Accrued Expenses, Other Current and Long-Term Liabilities, Changes in Operating Assets and Liabilities (USD, thousands)

Income Taxes, Changes in Operating Assets and Liabilities (USD, thousands)

Net Cash Provided by (Used in) Operating Activities (USD, thousands)

Purchases of Property and Equipment (USD, thousands)

Net Cash Used in Investing Activities (USD, thousands)

Repurchases of Common Stock (USD, thousands)

Cash Paid for Tax Withheld on Vested Restricted Stock Awards (USD, thousands)

Proceeds from Exercises of Equity Awards (USD, thousands)

Net Cash Used in Financing Activities (USD, thousands)

Exchange Rate Impact on Cash (USD, thousands)

Decrease in Cash and Cash Equivalents (USD, thousands)

Purchases of Property and Equipment Included in Accounts Payable and Accrued Expenses (USD, thousands)

Deferred Income Taxes (USD, thousands)

Cash and Cash Equivalents at Beginning of Period (USD, thousands)

Cash and Cash Equivalents at End of Period (USD, thousands)

ac3fb7f8e1eb67978fb7959aba13dd5d583d21874e69b657d170fc9ae48bae99

Cash and cash equivalents (USD, thousands)

Accounts receivable, net (USD, thousands)

Inventories (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Current assets held for sale (USD, thousands)

Total current assets (USD, thousands)

Property and equipment, net (USD, thousands)

Right-of-use assets (USD, thousands)

Other long-term assets (USD, thousands)

Notes receivable (USD, thousands)

Deferred tax assets (USD, thousands)

Intangible assets, net (USD, thousands)

Goodwill (USD, thousands)

Non-current assets held for sale (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued expenses and other current liabilities (USD, thousands)

Current liabilities held for sale (USD, thousands)

Total current liabilities (USD, thousands)

Other long-term liabilities (USD, thousands)

Lease liabilities (USD, thousands)

Non-current liabilities held for sale (USD, thousands)

Common stock (USD, thousands)

Additional paid-in-capital (USD, thousands)

Accumulated other comprehensive loss (USD, thousands)

Retained earnings (USD, thousands)

Total stockholders’ equity (USD, thousands)

Total liabilities and stockholders’ equity (USD, thousands)

0423d1b525bab418326bc7e2785f24dde3c0f5d71dfe7ed07e12268949819574

Number of full-time employees in the United States and Europe (employees)

db2c7784e13cc15dbf30cd52d16a66f9a97597f520ebde14de3331d55700f8ed

Revenue (USD, thousands)

Cost of Revenue (USD, thousands)

Gross Profit (USD, thousands)

Research & Development Expenses (USD, thousands)

Selling, General & Administrative Expenses (USD, thousands)

Total Operating Expenses (USD, thousands)

(Loss) Income from Operations (USD, thousands)

Interest and Other Income (Expense), Net (USD, thousands)

(Loss) Income Before Income Taxes (USD, thousands)

Provision for Income Taxes (USD, thousands)

(Loss) Income from Continuing Operations (USD, thousands)

Loss from Discontinued Operations, Net of Tax (USD, thousands)

ef5d46d8576ae23722bb3709a148d47fe4dbf351cd9137e5c56275f94496a7dd

OA Pain Management

Joint Preservation and Restoration

Non-Orthopedic

OEM Channel

Commercial Channel

Total Revenue

219cd31a93f49613a345ee7a289a518cfb9bc01fb33e0b7aa48af4c3a091404b

United States

Europe

Other

b3cbd9b7302accf9f4cc3a94a34daa44cccc9bcaf51e038652a6d2d2c7248065

Anika Therapeutics Inc (ANIK)

Financials